DERM Journey Medical Corporation - Common Stock
DERM لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
DERM مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
DERM توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 2 20,0%
- شراء 7 70,0%
- احتفاظ 1 10,0%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
4 محللين · 2026-08-18سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.01 | $-0.02 | 0.01% |
| 31 مارس، 2026 | $-0.08 | $-0.08 | -0.00% |
| 31 ديسمبر، 2025 | $-0.05 | $-0.06 | 0.01% |
| 30 سبتمبر، 2025 | $-0.09 | $-0.05 | -0.04% |
| 30 يونيو، 2025 | $-0.16 | $-0.11 | -0.05% |
| 31 مارس، 2025 | $-0.18 | $-0.24 | 0.06% |
| 31 ديسمبر، 2024 | $-0.15 | $-0.36 | 0.21% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| NMRA | $312M | -1.2 | — | — | -165.2% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| AARD | $286M | -4.5 | — | — | -47.3% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $62M | $56M | $79M | $74M | $63M | $45M | |
| Cost of Revenue | $21M | $21M | $23M | $31M | $32M | $15M | |
| R&D Expense | $480.0K | $10M | $8M | $11M | $3M | · | |
| SG&A Expense | $44M | $40M | $44M | $59M | $40M | $22M | |
| Operating Expenses | $70M | $70M | $81M | $101M | $98M | $37M | |
| Operating Income | $-8M | $-14M | $-2M | $-28M | $-35M | $8M | |
| Interest Expense | · | · | $2M | $2M | $7M | $698.0K | |
| Other Non-op | $-3M | $-934.0K | $-2M | $-2M | $-7M | $-698.0K | |
| Pretax Income | $-11M | $-15M | $-4M | $-30M | $-42M | $7M | |
| Income Tax | $60.0K | $61.0K | $221.0K | $63.0K | $2M | $2M | |
| Net Income | $-11M | $-15M | $-4M | $-30M | $-44M | $5M | |
| EPS (Basic) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.58 | |
| EPS (Diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 | |
| Shares (Basic) | 24,497,973 | 20,431,400 | 18,232,422 | 17,531,274 | 10,189,844 | 9,135,985 | |
| Shares (Diluted) | 24,497,973 | 20,431,400 | 18,232,422 | 17,531,274 | 10,189,844 | 10,836,122 | |
| EBITDA | $-8M | $-14M | $-2M | $-28M | $-35M | · |
الميزانية العمومية 22
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24M | $20M | $27M | $32M | $49M | $8M | |
| Receivables | $30M | $10M | $15M | $28M | $23M | $24M | |
| Inventory | $10M | $14M | $10M | $14M | $10M | $1M | |
| Prepaid Expense | $3M | $3M | $4M | $3M | $2M | $2M | |
| Current Assets | $67M | $48M | $56M | $78M | $84M | $35M | |
| PP&E (Gross) | · | · | · | · | · | $11.0K | |
| Accum. Depreciation | · | · | · | · | · | $11.0K | |
| Intangibles | $28M | $32M | $20M | $27M | $13M | $15M | |
| Other Non-current Assets | · | · | $6.0K | $95.0K | $150.0K | $6.0K | |
| Total Assets | $95M | $80M | $77M | $105M | $97M | $52M | |
| Accounts Payable | $9M | $16M | $18M | $37M | $23M | $2M | |
| Accrued Liabilities | $28M | $17M | $20M | $19M | $23M | $21M | |
| Current Liabilities | $37M | $35M | $42M | $67M | $52M | $28M | |
| Capital Leases | $18.0K | $118.0K | $9.0K | $108.0K | · | $97.0K | |
| Total Liabilities | $63M | $60M | $56M | $88M | $55M | $42M | |
| Long-term Debt | $25M | $25M | $15M | $28M | · | · | |
| Total Debt | $25M | $25M | $15M | $20M | · | · | |
| Paid-in Capital | $130M | $107M | $93M | $85M | $81M | $5M | |
| Retained Earnings | $-98M | $-87M | $-72M | $-69M | $-39M | $5M | |
| Stockholders' Equity | $32M | $20M | $20M | $17M | $42M | $10M | |
| Liabilities + Equity | $95M | $80M | $77M | $105M | $97M | $52M | |
| Shares Outstanding | · | · | · | · | 11,316,344 | 3,151,333 |
التدفق النقدي 15
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $0 | $5.0K | |
| Stock-based Comp | $6M | $6M | $3M | $4M | $2M | $153.0K | |
| Deferred Tax | · | · | · | · | $2M | $-335.0K | |
| Amort. of Intangibles | $4M | $3M | $4M | $4M | $2M | $1M | |
| Other Non-cash | · | · | · | · | $38M | · | |
| Operating Cash Flow | $-12M | $-9M | $5M | $-14M | $-2M | $5M | |
| CapEx | · | $15M | $5M | $20M | · | · | |
| Investing Cash Flow | · | $-15M | $-5M | $-20M | $-10M | $-1M | |
| Stock Issued | $16M | $8M | $4M | · | $33M | · | |
| Net Stock Activity | $16M | $8M | · | · | $33M | · | |
| Financing Cash Flow | $16M | $17M | $-5M | $16M | $53M | $-487.0K | |
| Net Change in Cash | $4M | $-7M | $-5M | $-17M | $41M | $3M | |
| Taxes Paid | $50.0K | $125.0K | $181.0K | $168.0K | $158.0K | $110.0K | |
| Free Cash Flow | · | $-24M | $240.0K | $-34M | · | · | |
| Levered FCF | · | · | $-2M | $-36M | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | · | |
| Net Margin | -18.5% | -26.1% | -4.9% | -40.2% | -69.7% | · | |
| Pretax Margin | -18.4% | -26.0% | -4.6% | -40.1% | -67.1% | · | |
| EBITDA Margin | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% | · | |
| ROA | -13.1% | -18.7% | -4.2% | -29.3% | -59.0% | · | |
| ROE | -44.7% | -94.7% | -20.4% | -137.3% | -290.1% | · | |
| ROIC | -14.4% | -30.6% | -6.3% | -74.9% | -86.2% | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.4 | 1.3 | 1.2 | 1.6 | · | |
| Quick Ratio | 1.4 | 0.9 | 1.0 | 0.9 | 1.4 | · | |
| Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · | · | |
| LT Debt / Equity | 0.8 | 1.2 | 0.7 | 1.2 | · | · | |
| Interest Coverage | · | · | -1.2 | -13.6 | -5.0 | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.9 | 0.7 | 0.8 | · | |
| Inventory Turnover | 1.7 | 1.7 | 2.2 | 2.6 | 5.7 | · | |
| Receivables Turnover | 3.1 | 4.4 | 3.6 | 2.9 | 2.7 | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -29.1% | 7.5% | 16.7% | 41.8% | · | |
| Revenue CAGR 3Y | -5.7% | -3.8% | 21.1% | · | · | · | |
| Revenue CAGR 5Y | 6.8% | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 4
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $62M | $56M | $79M | $74M | $63M | · | |
| Net Income TTM | $-11M | $-15M | $-4M | $-30M | $-44M | · | |
| P/E | -16.4 | -5.4 | -27.4 | -1.1 | -1.2 | · | |
| Earnings Yield | -6.1% | -18.4% | -3.6% | -88.0% | -80.3% | · |
قائمة الدخل 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $16M | $16M | $18M | $15M | $13M | $14M | $15M | $15M | $13M | $15M | $35M | $17M | $12M | $16M | $16M | |
| Cost of Revenue | $6M | $6M | · | · | $5M | $5M | $2M | $5M | $7M | $7M | $2M | $6M | $8M | $6M | $8M | $7M | |
| R&D Expense | $54.0K | · | $154.0K | $287.0K | $0 | $39.0K | $218.0K | $842.0K | $913.0K | $8M | $2M | $2M | $2M | $2M | $4M | $3M | |
| SG&A Expense | $11M | $10M | $10M | $12M | $12M | $11M | $10M | $11M | $10M | $8M | $10M | $9M | $12M | $13M | $14M | $16M | |
| Operating Expenses | $18M | $17M | $17M | $19M | $18M | $16M | $11M | $18M | $18M | $23M | $17M | $17M | $25M | $22M | $26M | $26M | |
| Operating Income | $456.0K | $-1M | $-443.0K | $-2M | $-3M | $-3M | $2M | $-3M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-10M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $548.0K | · | $268.0K | $756.0K | $650.0K | $617.0K | $559.0K | |
| Other Non-op | $-753.0K | $-738.0K | $-804.0K | $-786.0K | $-860.0K | $-749.0K | $-652.0K | $504.0K | $-434.0K | $-352.0K | $87.0K | $-361.0K | $-710.0K | $-575.0K | $-634.0K | $-578.0K | |
| Pretax Income | $-297.0K | $-2M | $-1M | $-2M | $-4M | $-4M | $2M | $-2M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-11M | $-10M | |
| Income Tax | $15.0K | · | $0 | $0 | $60.0K | · | · | · | · | · | $126.0K | $95.0K | · | · | $13.0K | $10.0K | |
| Net Income | $-312.0K | $-2M | $-1M | $-2M | $-4M | $-4M | $2M | $-2M | $-3M | $-10M | $-2M | $17M | $-8M | $-10M | $-11M | $-10M | |
| EPS (Basic) | $-0.01 | $-0.08 | $-0.04 | $-0.09 | $-0.16 | $-0.18 | $0.10 | $-0.12 | $-0.17 | $-0.53 | $-0.09 | $0.91 | $-0.46 | $-0.57 | $-0.61 | $-0.57 | |
| EPS (Diluted) | $-0.01 | $-0.08 | $-0.04 | $-0.09 | $-0.16 | $-0.18 | $0.10 | $-0.12 | $-0.17 | $-0.53 | $0.02 | $0.80 | $-0.46 | $-0.57 | $-0.61 | $-0.57 | |
| Shares (Basic) | 27,493,693 | 27,305,028 | -46,362,987 | 24,959,114 | 23,290,806 | 22,611,040 | -39,857,701 | 20,537,794 | 19,993,858 | 19,757,449 | -35,996,195 | 18,416,368 | 18,005,055 | 17,807,194 | -34,861,028 | 17,618,064 | |
| Shares (Diluted) | 27,493,693 | 27,305,028 | -46,362,987 | 24,959,114 | 23,290,806 | 22,611,040 | -39,857,701 | 20,537,794 | 19,993,858 | 19,757,449 | -38,614,585 | 21,034,758 | 18,005,055 | 17,807,194 | · | 17,618,064 | |
| EBITDA | $456.0K | $-1M | · | $-2M | $-3M | $-3M | · | $-3M | $-3M | $-10M | · | $17M | $-8M | $-10M | · | $-9M |
الميزانية العمومية 20
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $27M | $24M | $25M | $20M | $21M | $20M | $22M | $24M | $24M | $27M | $25M | $8M | $17M | $32M | $35M | |
| Receivables | $36M | $25M | $30M | $18M | $16M | $18M | $10M | $11M | $10M | $10M | $15M | $8M | $17M | $28M | $28M | $29M | |
| Inventory | $8M | $9M | $10M | $12M | $13M | $12M | $14M | $12M | $10M | $11M | $10M | $11M | $12M | $13M | $14M | $15M | |
| Prepaid Expense | $3M | $3M | $3M | $2M | $2M | $2M | $3M | $1M | $2M | $3M | $4M | $924.0K | $2M | $2M | $3M | $942.0K | |
| Current Assets | $73M | $65M | $67M | $56M | $51M | $54M | $48M | $46M | $46M | $47M | $56M | $45M | $48M | $61M | $78M | $80M | |
| Intangibles | $26M | $26M | $28M | $29M | $30M | $31M | $32M | $18M | $19M | $19M | $20M | $21M | $22M | $26M | $27M | $28M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $88.0K | $95.0K | $103.0K | |
| Total Assets | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M | $65M | $67M | $77M | $66M | $70M | $96M | $105M | $108M | |
| Accounts Payable | $8M | $8M | $9M | $12M | $13M | $14M | $16M | $15M | $15M | $15M | $18M | $28M | $32M | $44M | $37M | $34M | |
| Accrued Liabilities | $32M | $26M | $28M | $21M | $23M | $23M | $17M | $16M | $16M | $20M | $20M | $16M | $23M | $17M | $19M | $18M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Current Liabilities | $46M | $38M | $37M | $40M | $40M | $40M | $35M | $33M | $34M | $39M | $42M | $49M | $68M | $77M | $67M | $61M | |
| Capital Leases | · | · | $18.0K | $44.0K | $69.0K | $94.0K | $118.0K | · | · | · | $9.0K | $34.0K | $59.0K | $84.0K | $108.0K | · | |
| Total Liabilities | $66M | $61M | $63M | $59M | $62M | $63M | $60M | $53M | $54M | $54M | $56M | $49M | $70M | $88M | $88M | $82M | |
| Long-term Debt | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $20M | $20M | $15M | $15M | $0 | $10M | $23M | $28M | · | |
| Total Debt | $25M | $25M | · | $25M | $25M | $25M | · | $20M | $20M | $15M | · | · | $10M | $20M | · | $20M | |
| Paid-in Capital | $133M | $132M | $130M | $123M | $114M | $113M | $107M | $99M | $97M | $96M | $93M | $88M | $87M | $86M | $85M | $84M | |
| Retained Earnings | $-101M | $-101M | $-98M | $-97M | $-95M | $-91M | $-87M | $-89M | $-86M | $-83M | $-72M | $-70M | $-87M | $-79M | $-69M | $-58M | |
| Stockholders' Equity | $32M | $31M | $32M | $26M | $19M | $22M | $20M | $11M | $11M | $13M | $20M | $17M | $5.0K | $7M | $17M | $26M | |
| Liabilities + Equity | $98M | $92M | $95M | $85M | $81M | $85M | $80M | $64M | $65M | $67M | $77M | $66M | $70M | $96M | $105M | $108M |
التدفق النقدي 11
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $989.0K | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $529.0K | $558.0K | $873.0K | $646.0K | $1M | $1M | |
| Amort. of Intangibles | $969.0K | $1M | $1M | $1M | $1M | $1M | $982.0K | $814.0K | $814.0K | $814.0K | $815.0K | $814.0K | $1M | $1M | $1M | $1M | |
| Operating Cash Flow | $-2M | $3M | $-6M | $-2M | $-942.0K | $-3M | $2M | $-1M | $-5M | $-5M | $-17M | $19M | $4M | $-956.0K | $-4M | $-7M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $5M | $0 | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-5M | $0 | $0 | |
| Stock Issued | · | · | $5M | $7M | $0 | $4M | $6M | $194.0K | $0 | $1M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $4M | · | · | · | $1M | · | · | · | · | · | · | |
| Financing Cash Flow | $158.0K | $220.0K | $5M | $7M | $165.0K | $4M | $11M | $-294.0K | $5M | $2M | $19M | $-11M | $-13M | $52.0K | $948.0K | $4M | |
| Net Change in Cash | $-2M | $3M | $-858.0K | $5M | $-777.0K | $765.0K | $-2M | $-1M | $-145.0K | $-3M | $3M | $8M | $-9M | $-6M | $-3M | $-3M | |
| Taxes Paid | · | · | $1.0K | $0 | · | · | $21.0K | $1.0K | · | · | $96.0K | $0 | $78.0K | $7.0K | $149.0K | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-6M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.5% | -9.3% | · | -8.7% | -19.2% | -25.3% | · | -19.8% | -19.7% | -77.4% | · | 49.9% | -44.6% | -78.3% | · | -58.9% | |
| Net Margin | -1.7% | -14.0% | · | -13.1% | -25.3% | -31.0% | · | -16.3% | -22.6% | -80.1% | · | 48.6% | -48.7% | -83.0% | · | -62.5% | |
| Pretax Margin | -1.6% | -14.0% | · | -13.1% | -24.9% | -31.0% | · | -16.3% | -22.6% | -80.1% | · | 48.9% | -48.7% | -83.0% | · | -62.5% | |
| EBITDA Margin | 2.5% | -9.3% | · | -8.7% | -19.2% | -25.3% | · | -19.8% | -19.7% | -77.4% | · | 49.9% | -44.6% | -78.3% | · | -58.9% | |
| ROA | -0.35% | -2.5% | · | -3.1% | -5.2% | -5.4% | · | -3.7% | -5.0% | -12.9% | · | 19.3% | -9.1% | -9.3% | · | -10.2% | |
| ROE | -1.2% | -8.5% | · | -12.6% | -24.9% | -23.6% | · | -16.9% | -59.5% | -102.2% | · | 77.1% | -48.1% | -41.4% | · | -139.3% | |
| ROIC | 0.83% | · | · | · | -6.6% | · | · | · | · | · | · | 98.7% | · | · | · | -20.7% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 1.7 | · | 1.4 | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | |
| Quick Ratio | 1.4 | 1.4 | · | 1.1 | 0.9 | 1.0 | · | 1.0 | 1.0 | 0.9 | · | 0.7 | 0.4 | 0.6 | · | 1.0 | |
| Debt / Equity | 0.8 | 0.8 | · | 1.0 | 1.3 | 1.2 | · | 1.8 | 1.7 | 1.1 | · | · | 1988.4 | 2.6 | · | 0.8 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.8 | 1.1 | 1.1 | · | 1.8 | 1.7 | 1.1 | · | · | · | 1.3 | · | 0.8 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.4 | · | 64.3 | -10.1 | -14.7 | · | -17.0 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.6 | 0.6 | · | · | · | · | · | 0.5 | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.4 | · | 0.5 | |
| Receivables Turnover | 0.7 | 0.7 | · | 1.2 | 1.1 | 0.9 | · | 1.6 | 1.1 | 0.7 | · | 1.9 | 0.8 | 0.4 | · | 0.5 |
التقييم (آخر 12 شهرًا) 4
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $67M | $62M | · | $60M | $58M | $56M | · | $77M | $80M | $77M | · | $80M | $64M | $70M | · | $77M | |
| Net Income TTM | $-9M | $-12M | · | $-13M | $-14M | $-20M | · | $596.0K | $-5M | $-12M | · | $-12M | $-36M | $-29M | · | $-30M | |
| P/E | -20.8 | -9.2 | · | -12.9 | -11.4 | -5.9 | · | -282.5 | -15.7 | -4.8 | · | -3.4 | -0.8 | -1.0 | · | -1.1 | |
| Earnings Yield | -4.8% | -10.9% | · | -7.7% | -8.8% | -17.0% | · | -0.35% | -6.4% | -20.6% | · | -29.2% | -127.7% | -105.1% | · | -91.1% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $62M | $56M | $79M | $74M | $63M |
| هامش الربح التشغيلي % | -13.2% | -24.4% | -2.6% | -37.4% | -55.2% |
| صافي الدخل | $-11M | $-15M | $-4M | $-30M | $-44M |
| EPS المخفف | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.8 | 1.2 | 0.7 | 1.2 | — |
| النسبة الحالية | 1.8 | 1.4 | 1.3 | 1.2 | 1.6 |
| النسبة السريعة | 1.4 | 0.9 | 1.0 | 0.9 | 1.4 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | — | $-24M | $240.0K | $-34M | — |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 77 مقدمي إقرار · $66.8M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 29 (+18 مقابل الربع السابق) | 21 (+6 مقابل الربع السابق) | 20 (-7 مقابل الربع السابق) | 18 (-1 مقابل الربع السابق) | -2.1M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $11398800 | 1610000 | 17,06% | الأسهم |
| WASATCH ADVISORS LP | $10005505 | 2133370 | 14,98% | الأسهم |
| VANGUARD GROUP INC | $5122378 | 664381 | 7,67% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $4780310 | 675185 | 7,16% | الأسهم |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | $3794880 | 536000 | 5,68% | الأسهم |
| Pale Fire Capital SE | $3742375 | 528584 | 5,60% | الأسهم |
| Opaleye Management Inc. | $2478000 | 350000 | 3,71% | الأسهم |
| Summit Financial, LLC | $2454976 | 346748 | 3,68% | الأسهم |
| Diametric Capital, LP | $2093294 | 295663 | 3,13% | الأسهم |
| Ikarian Capital, LLC | $1780168 | 251436 | 2,66% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $1626276 | 229700 | 2,43% | الأسهم |
| AMERICAN FINANCIAL GROUP INC | $1274400 | 180000 | 1,91% | الأسهم |
| Trexquant Investment LP | $1213073 | 171338 | 1,82% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $1199494 | 169306 | 1,80% | الأسهم |
| J. Goldman & Co LP | $974095 | 137584 | 1,46% | الأسهم |
| Sheets Smith Investment Management | $946276 | 132904 | 1,42% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $778913 | 110016 | 1,17% | الأسهم |
| XTX Topco Ltd | $714535 | 100923 | 1,07% | الأسهم |
| JANE STREET GROUP, LLC | $683411 | 96527 | 1,02% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $670681 | 94729 | 1,00% | الأسهم |
| GOLDMAN SACHS GROUP INC | $639282 | 90294 | 0,96% | الأسهم |
| PVG ASSET MANAGEMENT CORP | $563377 | 79573 | 0,84% | الأسهم |
| Integrated Wealth Concepts LLC | $558809 | 78928 | 0,84% | الأسهم |
| BOOTHBAY FUND MANAGEMENT, LLC | $477489 | 67442 | 0,71% | الأسهم |
| STATE STREET CORP | $467124 | 65978 | 0,70% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $466041 | 65825 | 0,70% | الأسهم |
| Walleye Capital LLC | $463471 | 65462 | 0,69% | الأسهم |
| Geneos Wealth Management Inc. | $448022 | 63280 | 0,67% | الأسهم |
| Frec Markets, Inc. | $357540 | 50500 | 0,54% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $335670 | 47411 | 0,50% | الأسهم |
| Squarepoint Ops LLC | $321467 | 45405 | 0,48% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $296701 | 41907 | 0,44% | الأسهم |
| MORGAN STANLEY | $282343 | 39879 | 0,42% | الأسهم |
| ADAR1 Capital Management, LLC | $279780 | 39517 | 0,42% | الأسهم |
| STATE OF WISCONSIN INVESTMENT BOARD | $254200 | 35904 | 0,38% | الأسهم |
| NORTHERN TRUST CORP | $252444 | 35656 | 0,38% | الأسهم |
| Aster Capital Management (DIFC) Ltd | $217498 | 30720 | 0,33% | الأسهم |
| SALEM INVESTMENT COUNSELORS INC | $206736 | 29200 | 0,31% | الأسهم |
| Quadrature Capital Ltd | $204194 | 28841 | 0,31% | الأسهم |
| JANE STREET GROUP, LLC | $201072 | 28400 | 0,30% | عقد خيار الشراء |
| UBS Group AG | $162939 | 23014 | 0,24% | الأسهم |
| PRELUDE CAPITAL MANAGEMENT, LLC | $155087 | 21905 | 0,23% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $141607 | 20001 | 0,21% | الأسهم |
| Gladstone Institutional Advisory LLC | $141600 | 20000 | 0,21% | الأسهم |
| Brevan Howard Capital Management LP | $133508 | 18857 | 0,20% | الأسهم |
| Invesco Ltd. | $118087 | 16679 | 0,18% | الأسهم |
| Jefferies Financial Group Inc. | $117507 | 16597 | 0,18% | الأسهم |
| Mariner, LLC | $94505 | 13348 | 0,14% | الأسهم |
| BRIGHTON JONES LLC | $89931 | 12702 | 0,13% | الأسهم |
| MARSHALL WACE, LLP | $86820 | 12263 | 0,13% | الأسهم |
| Atria Investments, Inc | $84542 | 11941 | 0,13% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $80039 | 11305 | 0,12% | الأسهم |
| Persistent Asset Partners Ltd | $71381 | 10082 | 0,11% | الأسهم |
| OSAIC HOLDINGS, INC. | $63731 | 9002 | 0,10% | الأسهم |
| BlackRock, Inc. | $54842 | 7746 | 0,08% | الأسهم |
| Tower Research Capital LLC (TRC) | $41694 | 5889 | 0,06% | الأسهم |
| Vanguard Global Advisers, LLC | $32865 | 4642 | 0,05% | الأسهم |
| CITADEL ADVISORS LLC | $30876 | 4361 | 0,05% | الأسهم |
| CITIGROUP INC | $28823 | 4071 | 0,04% | الأسهم |
| BARCLAYS PLC | $16454 | 2324 | 0,02% | الأسهم |
| PNC Financial Services Group, Inc. | $8977 | 1268 | 0,01% | الأسهم |
| MERCER GLOBAL ADVISORS INC /ADV | $5721 | 808 | 0,01% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $5408 | 1153 | 0,01% | الأسهم |
| FMR LLC | $3370 | 476 | 0,01% | الأسهم |
| Russell Investments Group, Ltd. | $1763 | 249 | 0,00% | الأسهم |
| AQR CAPITAL MANAGEMENT LLC | $1147 | 162 | 0,00% | الأسهم |
| ROYAL BANK OF CANADA | $1000 | 92 | 0,00% | الأسهم |
| Arax Advisory Partners | $928 | 131 | 0,00% | الأسهم |
| JPMORGAN CHASE & CO | $278 | 41 | 0,00% | الأسهم |
| EverSource Wealth Advisors, LLC | $262 | 37 | 0,00% | الأسهم |
| CWM, LLC | $258 | 55 | 0,00% | الأسهم |
| Allworth Financial LP | $206 | 29 | 0,00% | الأسهم |
| ROTHSCHILD INVESTMENT LLC | $177 | 25 | 0,00% | الأسهم |
| Essential Partners LLC | $142 | 20 | 0,00% | الأسهم |
| Caitong International Asset Management Co., Ltd | $78 | 11 | 0,00% | الأسهم |
| Farther Finance Advisors, LLC | $42 | 6 | 0,00% | الأسهم |
| JPL Wealth Management, LLC | $15 | 2 | 0,00% | الأسهم |
المطلعون على الشركة 11 من المطلعين · مسؤولون 4 · مديرون 7
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Claude Maraoui | President & CEO | 22 إبريل، 2026 A | 2435990 | 0 | 0 | $0 |
| Joseph Benesch | CFO | 22 إبريل، 2026 A | 261371 | 0 | 0 | $0 |
| Ernest Robert De Paolantonio | As of the date of the original Form 4 filed on October 6, 2022, the Reporting Person was the Chief Financial Officer of the Issu | 4 أكتوبر، 2022 S | 259907 | 0 | 0 | $0 |
| Ramsey Alloush | Chief Operating Officer | 22 إبريل، 2026 A | 598543 | 0 | 0 | $0 |
| Justin Adam Smith | مدير | 1 يوليو، 2026 A | 231618 | 0 | 0 | $0 |
| Miranda Jayne Toledano | مدير | 1 يوليو، 2026 A | 168618 | 0 | 0 | $0 |
| Neil Herskowitz | مدير | 1 يوليو، 2026 A | 168618 | 0 | 0 | $0 |
| Michael Cooper Pearce | مدير | 25 يونيو، 2026 A | 67173 | 0 | 0 | $0 |
| Lindsay A. Rosenwald, M.D. | مدير | 25 يونيو، 2026 A | 221146 | 0 | 0 | $0 |
| Jeffrey Paley | مدير | 8 نوفمبر، 2023 S | 114217 | 0 | 0 | $0 |
| Fortress Biotech, Inc. | مالك 10% | 12 مايو، 2023 J | 3860467 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 9 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,50% | 17742 SH | 8 أغسطس، 2026 | يومي |
| IWC · iShares Trust | 0,02% | 50931 SH | 8 أغسطس، 2026 | يومي |
| ITWO · ProShares Trust | 0,00% | 973 NS | 31 مايو، 2026 | N-PORT |
| RSSL · Global X Funds | 0,00% | 8939 NS | 30 إبريل، 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 760 NS | 31 مايو، 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 766 NS | 31 مايو، 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 19 NS | 31 مايو، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 186966 SH | 8 أغسطس، 2026 | يومي |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 470426 SH | 8 أغسطس، 2026 | يومي |